This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Catamaran's BriovaRx Receives URAC Specialty Pharmacy Accreditation

Stocks in this article: CTRX

LISLE, IL, April 4, 2013 /PRNewswire/ - Catamaran Corp. (NASDAQ: CTRX), (TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology today announced that its specialty brand, BriovaRxâ„¢, has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based accrediting organization that establishes quality standards for the healthcare industry.

"BriovaRx's robust offerings focus on the patient, ensuring one-on-one support and a personalized plan that addresses chronic conditions to help them lead healthy, vibrant lives," said Mark Thierer, Chairman and CEO of Catamaran. "The URAC accreditation is a reflection of BriovaRx's patient-centric approach that coordinates the efforts of providers, payers and manufacturers to keep treatments personalized and successful."

Designed as a better alternative to other specialty pharmacy offerings, BriovaRx is a high-touch, comprehensive care system of pharmacological care where patients with chronic illnesses and complex diseases receive expert therapy management and support tailored to their individual needs.

URAC made the decision to develop a Specialty Pharmacy accreditation program because it is one of the key distribution channels for pharmacy benefit management and extends URAC's consumer protection and empowerment efforts in managed care pharmacy. URAC offers the only third-party, voluntary accreditation program of this scope for pharmacy benefit management and prescription services industry.

"The URAC accreditation is a recognition of the quality and broad scope of our specialty pharmacy offering," said Albert Thigpen, Senior Vice President, Pharmacy Operations of Catamaran. "As the fifth largest specialty pharmacy in the nation, BriovaRx has the skill and scale to effectively manage costs for health plans and other payers challenged by escalating specialty drug prices and increased utilization. We look forward to continuing to deliver personalized care and committed support to our patients."

"By applying for and receiving URAC accreditation, BriovaRx has demonstrated a commitment to quality healthcare," said Alan P. Spielman, URAC president and CEO. "Quality healthcare is crucial to our nation's welfare and it is important to have organizations that are willing to measure themselves against national standards and undergo rigorous evaluation by an independent accrediting body."

About Catamaran Catamaran, the industry's fastest-growing pharmacy benefit manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 250 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Ill. with multiple locations in the U.S. and Canada. For more information, please visit www.catamaranRx.com. Follow us on Twitter @CatamaranCorp or www.twitter.com/catamarancorp.

About URAC URAC, an independent, nonprofit organization, is a leader in promoting health care quality through accreditation and certification programs. URAC's standards keep pace with the rapid changes in the health care system, and provide a mark of distinction for health care organizations to demonstrate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in setting meaningful standards for the health care industry. For more information, visit www.urac.org.

SOURCE Catamaran

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,659.53 -13.07 -0.07%
S&P 500 2,053.37 +1.55 0.08%
NASDAQ 4,762.8050 +4.9260 0.10%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs